BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12165029)

  • 1. Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures.
    Treiber G; Ammon S; Malfertheiner P; Klotz U
    Helicobacter; 2002 Aug; 7(4):225-31. PubMed ID: 12165029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
    Sotoudehmanesh R; Malekzadeh R; Vahedi H; Dariani NE; Asgari AA; Massarrat S
    Digestion; 2001; 64(4):222-5. PubMed ID: 11842278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
    Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
    World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N; Burm M; Faigel D; Kelly C; Peterson W; Fennerty MB
    Dig Dis; 2001; 19(2):174-8. PubMed ID: 11549829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified bismuth-containing quadruple therapy including a short course of furazolidone for Helicobacter pylori eradication after sequential therapy failure.
    Fakheri H; Bari Z; Sardarian H
    Helicobacter; 2012 Aug; 17(4):264-8. PubMed ID: 22759325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
    Gisbert JP; Pajares JM
    Helicobacter; 2005 Oct; 10(5):363-72. PubMed ID: 16181345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
    Tang D; Yuan L; Yue C; Cai T; Yao Y; Wang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):772-778. PubMed ID: 30124214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new look at anti-Helicobacter pylori therapy.
    Chuah SK; Tsay FW; Hsu PI; Wu DC
    World J Gastroenterol; 2011 Sep; 17(35):3971-5. PubMed ID: 22046084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.
    Isakov V; Domareva I; Koudryavtseva L; Maev I; Ganskaya Z
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1277-82. PubMed ID: 12144577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
    Branquinho D; Almeida N; Gregório C; Cabral JE; Casela A; Donato MM; Tomé L
    BMC Gastroenterol; 2017 Feb; 17(1):31. PubMed ID: 28202013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
    Nagahara A; Miwa H; Ogawa K; Kurosawa A; Ohkura R; Iida N; Sato N
    Helicobacter; 2000 Jun; 5(2):88-93. PubMed ID: 10849057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.
    Liang X; Xu X; Zheng Q; Zhang W; Sun Q; Liu W; Xiao S; Lu H
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):802-7.e1. PubMed ID: 23376004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg).
    Nyssen OP; Pérez-Aisa Á; Tepes B; Rodrigo-Sáez L; Romero PM; Lucendo A; Castro-Fernández M; Phull P; Barrio J; Bujanda L; Ortuño J; Areia M; Brglez Jurecic N; Huguet JM; Alcaide N; Voynovan I; María Botargues Bote J; Modolell I; Pérez Lasala J; Ariño I; Jonaitis L; Dominguez-Cajal M; Buzas G; Lerang F; Perona M; Bordin D; Axon T; Gasbarrini A; Marcos Pinto R; Niv Y; Kupcinskas L; Tonkic A; Leja M; Rokkas T; Boyanova L; Shvets O; Venerito M; Bytzer P; Goldis A; Simsek I; Lamy V; Przytulski K; Kunovský L; Capelle L; Milosavljevic T; Caldas M; Garre A; Mégraud F; O'Morain C; Gisbert JP;
    Helicobacter; 2020 Jun; 25(3):e12686. PubMed ID: 32173974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
    Zhang W; Chen Q; Liang X; Liu W; Xiao S; Graham DY; Lu H
    Gut; 2015 Nov; 64(11):1715-20. PubMed ID: 26338726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.